Electra Prices Upsized $350 Million IPO

Company Electra Therapeutics Event Type Initial Public Offering (Upsized Pricing) Platform SIRP-Directed Monoclonal Antibody Indication Secondary Hemophagocytic Lymphohistiocytosis Summary Electra Therapeutics priced an upsized initial public offering of 23,333,334 shares at $15 each for expected gross proceeds of approximately $350 million, before underwriting discounts and…